Global and USA Meningococcal Group B Vaccine Market Insights, Forecast to 2027

Meningococcal Group B Vaccine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Group B Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For USA market, this report focuses on the Meningococcal Group B Vaccine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in USA.

Bexsero

Trumenba

Other

Public

Private

North America

the United States

Canada

Europe

Germany

France

UK

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

GSK

Pfizer

1.1 Meningococcal Group B Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Type

1.2.2 Bexsero

1.2.3 Trumenba

1.2.4 Other

1.3 Market by Application

1.3.1 Global Meningococcal Group B Vaccine Market Size Growth Rate by Application

1.3.2 Public

1.3.3 Private

1.4 Study Objectives

1.5 Years Considered

2.1 Global Meningococcal Group B Vaccine Market Size, Estimates and Forecasts

2.1.1 Global Meningococcal Group B Vaccine Revenue 2016-2027

2.1.2 Global Meningococcal Group B Vaccine Sales 2016-2027

2.2 Global Meningococcal Group B Vaccine, Market Size by Region: 2016 VS 2021 VS 2027

2.3 Meningococcal Group B Vaccine Historical Market Size by Region (2016-2021)

2.3.1 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021

2.3.2 Global Meningococcal Group B Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021

2.4 Meningococcal Group B Vaccine Market Estimates and Projections by Region (2022-2027)

2.4.1 Global Meningococcal Group B Vaccine Sales Forecast by Region (2022-2027)

2.4.2 Global Meningococcal Group B Vaccine Revenue Forecast by Region (2022-2027)

3.1 Global Top Meningococcal Group B Vaccine Manufacturers by Sales

3.1.1 Global Meningococcal Group B Vaccine Sales by Manufacturer (2016-2021)

3.1.2 Global Meningococcal Group B Vaccine Sales Market Share by Manufacturer (2016-2021)

3.2 Global Top Meningococcal Group B Vaccine Manufacturers by Revenue

3.2.1 Key Meningococcal Group B Vaccine Manufacturers Covered: Ranking by Revenue

3.2.2 Global Meningococcal Group B Vaccine Revenue by Manufacturers (2016-2021)

3.2.3 Global Meningococcal Group B Vaccine Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Meningococcal Group B Vaccine Market Concentration Ratio (CR5 and HHI) (2016-2021)

3.2.5 Global Top 10 and Top 5 Companies by Meningococcal Group B Vaccine Revenue in 2020

3.2.6 Global Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.3 Global Meningococcal Group B Vaccine Price by Manufacturers

3.4 Global Meningococcal Group B Vaccine Manufacturing Base Distribution, Product Types

3.4.1 Meningococcal Group B Vaccine Manufacturers Manufacturing Base Distribution, Headquarters

3.4.2 Manufacturers Meningococcal Group B Vaccine Product Type

3.4.3 Date of International Manufacturers Enter into Meningococcal Group B Vaccine Market

3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4.1 Global Meningococcal Group B Vaccine Market Size by Type (2016-2021)

4.1.1 Global Meningococcal Group B Vaccine Sales by Type (2016-2021)

4.1.2 Global Meningococcal Group B Vaccine Revenue by Type (2016-2021)

4.1.3 Meningococcal Group B Vaccine Average Selling Price (ASP) by Type (2016-2021)

4.2 Global Meningococcal Group B Vaccine Market Size Forecast by Type (2022-2027)

4.2.1 Global Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027)

4.2.2 Global Meningococcal Group B Vaccine Revenue Forecast by Type (2022-2027)

4.2.3 Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027)

5.1 Global Meningococcal Group B Vaccine Market Size by Application (2016-2021)

5.1.1 Global Meningococcal Group B Vaccine Sales by Application (2016-2021)

5.1.2 Global Meningococcal Group B Vaccine Revenue by Application (2016-2021)

5.1.3 Meningococcal Group B Vaccine Price by Application (2016-2021)

5.2 Meningococcal Group B Vaccine Market Size Forecast by Application (2022-2027)

5.2.1 Global Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027)

5.2.2 Global Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027)

5.2.3 Global Meningococcal Group B Vaccine Price Forecast by Application (2022-2027)

6.1 USA Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027

6.1.1 USA Meningococcal Group B Vaccine Sales YoY Growth 2016-2027

6.1.2 USA Meningococcal Group B Vaccine Revenue YoY Growth 2016-2027

6.1.3 USA Meningococcal Group B Vaccine Market Share in Global Market 2016-2027

6.2 USA Meningococcal Group B Vaccine Market Size by Players (International and Local Players)

6.2.1 USA Top Meningococcal Group B Vaccine Players by Sales (2016-2021)

6.2.2 USA Top Meningococcal Group B Vaccine Players by Revenue (2016-2021)

6.3 USA Meningococcal Group B Vaccine Historic Market Review by Type (2016-2021)

6.3.1 USA Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)

6.3.2 USA Meningococcal Group B Vaccine Revenue Market Share by Type (2016-2021)

6.3.3 USA Meningococcal Group B Vaccine Price by Type (2016-2021)

6.4 USA Meningococcal Group B Vaccine Market Estimates and Forecasts by Type (2022-2027)

6.4.1 USA Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027)

6.4.2 USA Meningococcal Group B Vaccine Revenue Forecast by Type (2022-2027)

6.4.3 USA Meningococcal Group B Vaccine Price Forecast by Type (2022-2027)

6.5 USA Meningococcal Group B Vaccine Historic Market Review by Application (2016-2021)

6.5.1 USA Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)

6.5.2 USA Meningococcal Group B Vaccine Revenue Market Share by Application (2016-2021)

6.5.3 USA Meningococcal Group B Vaccine Price by Application (2016-2021)

6.6 USA Meningococcal Group B Vaccine Market Estimates and Forecasts by Application (2022-2027)

6.6.1 USA Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027)

6.6.2 USA Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027)

6.6.3 USA Meningococcal Group B Vaccine Price Forecast by Application (2022-2027)

7.1 North America Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027

7.2 North America Meningococcal Group B Vaccine Market Facts & Figures by Country

7.2.1 North America Meningococcal Group B Vaccine Sales by Country (2016-2021)

7.2.2 North America Meningococcal Group B Vaccine Revenue by Country (2016-2021)

7.2.3 the United States

7.2.4 Canada

8.1 Asia Pacific Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027

8.2 Asia Pacific Meningococcal Group B Vaccine Market Facts & Figures by Region

8.2.1 Asia Pacific Meningococcal Group B Vaccine Sales by Region (2016-2021)

8.2.2 Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2016-2021)

8.2.3 China

8.2.4 Japan

8.2.5 South Korea

8.2.6 India

8.2.7 Australia

8.2.8 Australia

8.2.9 Indonesia

8.2.10 Thailand

8.2.11 Malaysia

9.1 Europe Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027

9.2 Europe Meningococcal Group B Vaccine Market Facts & Figures by Country

9.2.1 Europe Meningococcal Group B Vaccine Sales by Country (2016-2021)

9.2.2 Europe Meningococcal Group B Vaccine Revenue by Country (2016-2021)

9.2.3 Germany

9.2.4 France

9.2.5 UK

9.2.6 Italy

10.1 Latin America Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027

10.2 Latin America Meningococcal Group B Vaccine Market Facts & Figures by Country

10.2.1 Latin America Meningococcal Group B Vaccine Sales by Country (2016-2021)

10.2.2 Latin America Meningococcal Group B Vaccine Revenue by Country (2016-2021)

10.2.3 Mexico

10.2.4 Brazil

10.2.5 Argentina

11.1 Middle East and Africa Meningococcal Group B Vaccine Market Size YoY Growth 2016-2027

11.2 Middle East and Africa Meningococcal Group B Vaccine Market Facts & Figures by Country

11.2.1 Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2016-2021)

11.2.2 Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2016-2021)

11.2.3 Turkey

11.2.4 Saudi Arabia

11.2.5 UAE

12.1 GSK

12.1.1 GSK Corporation Information

12.1.2 GSK Description and Business Overview

12.1.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)

12.1.4 GSK Meningococcal Group B Vaccine Products Offered

12.1.5 GSK Recent Development

12.2 Pfizer

12.2.1 Pfizer Corporation Information

12.2.2 Pfizer Description and Business Overview

12.2.3 Pfizer Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)

12.2.4 Pfizer Meningococcal Group B Vaccine Products Offered

12.2.5 Pfizer Recent Development

12.11 GSK

12.11.1 GSK Corporation Information

12.11.2 GSK Description and Business Overview

12.11.3 GSK Meningococcal Group B Vaccine Sales, Revenue and Gross Margin (2016-2021)

12.11.4 GSK Meningococcal Group B Vaccine Products Offered

12.11.5 GSK Recent Development

13.1 Meningococcal Group B Vaccine Industry Trends

13.2 Meningococcal Group B Vaccine Market Drivers

13.3 Meningococcal Group B Vaccine Market Challenges

13.4 Meningococcal Group B Vaccine Market Restraints

14.1 Value Chain Analysis

14.2 Meningococcal Group B Vaccine Customers

14.3 Sales Channels Analysis

14.3.1 Sales Channels

14.3.2 Distributors

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

List of Tables

    Table 1. Global Meningococcal Group B Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

    Table 2. Major Manufacturers of Bexsero

    Table 3. Major Manufacturers of Trumenba

    Table 4. Major Manufacturers of Other

    Table 5. Global Meningococcal Group B Vaccine Market Size Growth Rate by Application (2021-2027) & (K Units)

    Table 6. Global Meningococcal Group B Vaccine Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027

    Table 7. Global Meningococcal Group B Vaccine Sales by Regions (2016-2021) & (K Units)

    Table 8. Global Meningococcal Group B Vaccine Sales Market Share by Regions (2016-2021)

    Table 9. Global Meningococcal Group B Vaccine Revenue by Regions (2016-2021) & (US$ Million)

    Table 10. Global Meningococcal Group B Vaccine Sales Forecast by Region (2022-2027) & (K Units)

    Table 11. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Region (2022-2027)

    Table 12. Global Meningococcal Group B Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million)

    Table 13. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Region (2022-2027)

    Table 14. Global Meningococcal Group B Vaccine Sales by Manufacturers (2016-2021) (K Units)

    Table 15. Global Meningococcal Group B Vaccine Sales Share by Manufacturers (2016-2021)

    Table 16. Ranking of Global Top Meningococcal Group B Vaccine Manufacturers by Revenue (US$ Million) in 2020

    Table 17. Meningococcal Group B Vaccine Revenue by Manufacturers (2016-2021) (US$ Million)

    Table 18. Meningococcal Group B Vaccine Revenue Share by Manufacturers (2016-2021)

    Table 19. Global Meningococcal Group B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)

    Table 20. Global Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningococcal Group B Vaccine as of 2020)

    Table 21. Key Manufacturers Meningococcal Group B Vaccine Price (2016-2021) (USD/Unit)

    Table 22. Meningococcal Group B Vaccine Manufacturers Manufacturing Base Distribution and Headquarters

    Table 23. Manufacturers Meningococcal Group B Vaccine Product Type

    Table 24. Date of International Manufacturers Enter into Meningococcal Group B Vaccine Market

    Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 26. Global Meningococcal Group B Vaccine Sales by Type (2016-2021) (K Units)

    Table 27. Global Meningococcal Group B Vaccine Sales Share by Type (2016-2021)

    Table 28. Global Meningococcal Group B Vaccine Revenue by Type (2016-2021) (US$ Million)

    Table 29. Global Meningococcal Group B Vaccine Revenue Share by Type (2016-2021)

    Table 30. Meningococcal Group B Vaccine Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)

    Table 31. Global Meningococcal Group B Vaccine Sales Forecast by Type (2022-2027) & (K Units)

    Table 32. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Type (2022-2027)

    Table 33. Global Meningococcal Group B Vaccine Revenue Forecast V (2022-2027) & (US$ Million)

    Table 34. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Type (2022-2027)

    Table 35. Global Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)

    Table 36. Global Meningococcal Group B Vaccine Sales by Application (2016-2021) (K Units)

    Table 37. Global Meningococcal Group B Vaccine Sales Share by Application (2016-2021)

    Table 38. Global Meningococcal Group B Vaccine Revenue by Application (2016-2021) (US$ Million)

    Table 39. Global Meningococcal Group B Vaccine Revenue Share by Application (2016-2021)

    Table 40. Meningococcal Group B Vaccine Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)

    Table 41. Global Meningococcal Group B Vaccine Sales Forecast by Application (2022-2027) & (K Units)

    Table 42. Global Meningococcal Group B Vaccine Sales Market Share Forecast by Application (2022-2027)

    Table 43. Global Meningococcal Group B Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million)

    Table 44. Global Meningococcal Group B Vaccine Revenue Market Share Forecast by Application (2022-2027)

    Table 45. Global Meningococcal Group B Vaccine Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)

    Table 46. USA Meningococcal Group B Vaccine Sales (K Units) of Key Companies (2016-2021)

    Table 47. USA Meningococcal Group B Vaccine Sales Share by Company (2016-2021)

    Table 48. USA Meningococcal Group B Vaccine Revenue (US$ Million) by Company (2016-2021)

    Table 49. USA Meningococcal Group B Vaccine Revenue Share by Company (2016-2021)

    Table 50. USA Meningococcal Group B Vaccine Sales (K Units) by Type (2016-2021)

    Table 51. USA Meningococcal Group B Vaccine Sales Share by Type (2016-2021)

    Table 52. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)

    Table 53. USA Meningococcal Group B Vaccine Price (USD/Unit) by Type (2016-2021)

    Table 54. USA Meningococcal Group B Vaccine Sales (K Units) by Type (2022-2027)

    Table 55. USA Meningococcal Group B Vaccine Sales Share by Type (2022-2027)

    Table 56. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Type (2022-2027)

    Table 57. USA Meningococcal Group B Vaccine Revenue Share by Type (2022-2027)

    Table 58. USA Meningococcal Group B Vaccine Price (USD/Unit) by Type (2022-2027)

    Table 59. USA Meningococcal Group B Vaccine Sales (K Units) by Application (2016-2021)

    Table 60. USA Meningococcal Group B Vaccine Sales Share by Application (2016-2021)

    Table 61. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)

    Table 62. USA Meningococcal Group B Vaccine Price (USD/Unit) by Application (2016-2021)

    Table 63. USA Meningococcal Group B Vaccine Sales (K Units) by Application (2022-2027)

    Table 64. USA Meningococcal Group B Vaccine Sales Share by Application (2022-2027)

    Table 65. USA Meningococcal Group B Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)

    Table 66. USA Meningococcal Group B Vaccine Revenue Share by Application (2022-2027)

    Table 67. USA Meningococcal Group B Vaccine Price (USD/Unit) by Application (2022-2027)

    Table 68. North America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)

    Table 69. North America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)

    Table 70. North America Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 71. North America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)

    Table 72. Asia Pacific Meningococcal Group B Vaccine Sales by Region (2016-2021) & (K Units)

    Table 73. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)

    Table 74. Asia Pacific Meningococcal Group B Vaccine Revenue by Region (2016-2021) & (US$ Million)

    Table 75. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)

    Table 76. Europe Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)

    Table 77. Europe Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)

    Table 78. Europe Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 79. Europe Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)

    Table 80. Latin America Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)

    Table 81. Latin America Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)

    Table 82. Latin Americaa Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 83. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)

    Table 84. Middle East and Africa Meningococcal Group B Vaccine Sales by Country (2016-2021) & (K Units)

    Table 85. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country (2016-2021)

    Table 86. Middle East and Africa Meningococcal Group B Vaccine Revenue by Country (2016-2021) & (US$ Million)

    Table 87. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country (2016-2021)

    Table 88. GSK Corporation Information

    Table 89. GSK Description and Business Overview

    Table 90. GSK Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 91. GSK Meningococcal Group B Vaccine Product

    Table 92. GSK Recent Development

    Table 93. Pfizer Corporation Information

    Table 94. Pfizer Description and Business Overview

    Table 95. Pfizer Meningococcal Group B Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)

    Table 96. Pfizer Product

    Table 97. Pfizer Recent Development

    Table 98. Meningococcal Group B Vaccine Market Trends

    Table 99. Meningococcal Group B Vaccine Market Drivers

    Table 100. Meningococcal Group B Vaccine Market Challenges

    Table 101. Meningococcal Group B Vaccine Market Restraints

    Table 102. Meningococcal Group B Vaccine Customers List

    Table 103. Meningococcal Group B Vaccine Distributors List

    Table 104. Research Programs/Design for This Report

    Table 105. Key Data Information from Secondary Sources

    Table 106. Key Data Information from Primary Sources

List of Figures

    Figure 1. Meningococcal Group B Vaccine Product Picture

    Figure 2. Global Meningococcal Group B Vaccine Sales Market Share by Type in 2020 & 2027

    Figure 3. Bexsero Product Picture

    Figure 4. Trumenba Product Picture

    Figure 5. Other Product Picture

    Figure 6. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2020 & 2027

    Figure 7. Public

    Figure 8. Private

    Figure 9. Meningococcal Group B Vaccine Report Years Considered

    Figure 10. Global Meningococcal Group B Vaccine Market Size, (US$ Million), 2016 VS 2021 VS 2027

    Figure 11. Global Meningococcal Group B Vaccine Market Size 2016-2027 (US$ Million)

    Figure 12. Global Meningococcal Group B Vaccine Sales 2016-2027 (K Units)

    Figure 13. Global Meningococcal Group B Vaccine Market Size Market Share by Region: 2021 Versus 2027

    Figure 14. Global Meningococcal Group B Vaccine Sales Market Share by Region (2016-2021)

    Figure 15. Global Meningococcal Group B Vaccine Sales Market Share by Region in 2020

    Figure 16. Global Meningococcal Group B Vaccine Revenue Market Share by Region (2016-2021)

    Figure 17. Global Meningococcal Group B Vaccine Revenue Market Share by Region in 2020

    Figure 18. Global Meningococcal Group B Vaccine Sales Share by Manufacturer in 2020

    Figure 19. The Top 10 and 5 Players Market Share by Meningococcal Group B Vaccine Revenue in 2020

    Figure 20. Meningococcal Group B Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

    Figure 21. Global Meningococcal Group B Vaccine Sales Market Share by Type (2016-2021)

    Figure 22. Global Meningococcal Group B Vaccine Sales Market Share by Type in 2020

    Figure 23. Global Meningococcal Group B Vaccine Revenue Market Share by Type (2016-2021)

    Figure 24. Global Meningococcal Group B Vaccine Revenue Market Share by Type in 2020

    Figure 25. Global Meningococcal Group B Vaccine Sales Market Share by Application (2016-2021)

    Figure 26. Global Meningococcal Group B Vaccine Sales Market Share by Application in 2020

    Figure 27. Global Meningococcal Group B Vaccine Revenue Market Share by Application (2016-2021)

    Figure 28. Global Meningococcal Group B Vaccine Revenue Market Share by Application in 2020

    Figure 29. USA Meningococcal Group B Vaccine Sales Growth Rate 2016-2027 (K Units)

    Figure 30. USA Meningococcal Group B Vaccine Revenue Growth Rate 2016-2027 (US$ Million)

    Figure 31. USA Meningococcal Group B Vaccine Market Share in Global Market 2016-2027

    Figure 32. USA 5 and 10 Largest Meningococcal Group B Vaccine Players Market Share by Revenue in Meningococcal Group B Vaccine in 2020

    Figure 33. USA Meningococcal Group B Vaccine Revenue Share by Type (2016-2021)

    Figure 34. USA Meningococcal Group B Vaccine Revenue Growth Rate by Type in 2016 & 2020

    Figure 35. USA Meningococcal Group B Vaccine Revenue Share by Application (2016-2021)

    Figure 36. USA Meningococcal Group B Vaccine Revenue Growth Rate by Application in 2016 & 2020

    Figure 37. North America Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)

    Figure 38. North America Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 39. North America Meningococcal Group B Vaccine Sales Market Share by Country in 2020

    Figure 40. North America Meningococcal Group B Vaccine Revenue Market Share by Country in 2020

    Figure 41. the United States Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 42. the United States Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 43. Canada Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 44. Canada Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 45. Europe Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)

    Figure 46. Europe Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 47. Europe Meningococcal Group B Vaccine Sales Market Share by Country in 2020

    Figure 48. Europe Meningococcal Group B Vaccine Revenue Market Share by Country in 2020

    Figure 49. Germany Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 50. Germany Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 51. France Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 52. France Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 53. UK Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 54. UK Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 55. Italy Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 56. Italy Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 57. Russia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 58. Russia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 59. Asia Pacific Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)

    Figure 60. Asia Pacific Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 61. Asia Pacific Meningococcal Group B Vaccine Sales Market Share by Region in 2020

    Figure 62. Asia Pacific Meningococcal Group B Vaccine Revenue Market Share by Region in 2020

    Figure 63. China Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 64. China Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 65. Japan Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 66. Japan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 67. South Korea Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 68. South Korea Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 69. India Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 70. India Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 71. Australia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 72. Australia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 73. China Taiwan Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 74. China Taiwan Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 75. Indonesia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 76. Indonesia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 77. Thailand Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 78. Thailand Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 79. Malaysia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 80. Malaysia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 81. Latin America Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)

    Figure 82. Latin America Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 83. Latin America Meningococcal Group B Vaccine Sales Market Share by Country in 2020

    Figure 84. Latin America Meningococcal Group B Vaccine Revenue Market Share by Country in 2020

    Figure 85. Mexico Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 86. Mexico Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 87. Brazil Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 88. Brazil Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 89. Argentina Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 90. Argentina Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 91. Middle East and Africa Meningococcal Group B Vaccine Sales Growth Rate 2016-2021 (K Units)

    Figure 92. Middle East and Africa Meningococcal Group B Vaccine Revenue Growth Rate 2016-2021 (US$ Million)

    Figure 93. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Country in 2020

    Figure 94. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Country in 2020

    Figure 95. Turkey Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 96. Turkey Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 97. Saudi Arabia Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 98. Saudi Arabia Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 99. UAE Meningococcal Group B Vaccine Sales Growth Rate (2016-2021) (K Units)

    Figure 100. UAE Meningococcal Group B Vaccine Revenue Growth Rate (2016-2021) (US$ Million)

    Figure 101. Meningococcal Group B Vaccine Value Chain

    Figure 102. Channels of Distribution

    Figure 103. Distributors Profiles

    Figure 104. Bottom-up and Top-down Approaches for This Report

    Figure 105. Data Triangulation

    Figure 106. Key Executives Interviewed